Suppr超能文献

手术切除的肺腺癌患者重排的临床病理特征及预后意义:一项倾向评分匹配研究

Clinicopathological and Prognostic Significance of Rearrangement in Patients with Surgically Resected Lung Adenocarcinoma: A Propensity Score Matching Study.

作者信息

Shi Jinghan, Gu Weiqing, Zhao Yanfeng, Zhu Junjie, Jiang Gening, Bao Minwei, Shi Jingyun

机构信息

Department of Thoracic Surgery, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, People's Republic of China.

Department of Oncology, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Jan 24;12:589-598. doi: 10.2147/CMAR.S229217. eCollection 2020.

Abstract

OBJECTIVE

The echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase () fusion gene is a key oncogenic driver in non-small cell lung cancer (NSCLC). This study analyzed the clinicopathological characteristics and prognostic significance of fusion gene in patients with surgically resected adenocarcinoma.

METHODS

The clinicopathological characteristics of 1056 consecutive patients with surgically resected stage I-IIIA adenocarcinoma were collected from February 2014 to October 2014, and rearrangement was detected using real-time polymerase chain reaction (RT-PCR) technology. To compare the imaging and pathological features, a propensity score matching (PSM) method was performed. The follow-up information was collected to evaluate the long-term outcomes of patients with rearrangement.

RESULTS

The prevalence of rearrangement was 6.6% in 1056 consecutive patients. A total of 70 positive and 210 negative patients were identified after PSM. Imaging and pathological analyses showed that rearrangement was significantly associated with less ground-glass opacity (GGO) (adjusted OR=1.38, 95% CI=1.03-1.85, =0.029) and higher prevalence of non-invasive mucinous adenocarcinoma mucin-laden adenocarcinomas (non-IMA MLA, adjusted OR=6.79, 95% CI=2.69-17.17, <0.001). rearrangement was found to be an unfavorable prognostic factor for disease-free survival (DFS) in female patients (HR=2.26, 95% CI=1.13-4.53, =0.021).

CONCLUSION

Our results suggest that adenocarcinomas harboring fusion gene exhibit specific radiological and pathological characteristics compared with negative adenocarcinomas. In female patients, rearrangement was associated with shorter DFS.

摘要

目的

棘皮动物微管相关蛋白样4-间变性淋巴瘤激酶()融合基因是非小细胞肺癌(NSCLC)的关键致癌驱动因素。本研究分析了手术切除的腺癌患者中融合基因的临床病理特征及预后意义。

方法

收集2014年2月至2014年10月连续1056例手术切除的Ⅰ-ⅢA期腺癌患者的临床病理特征,采用实时聚合酶链反应(RT-PCR)技术检测重排情况。为比较影像学和病理特征,采用倾向评分匹配(PSM)方法。收集随访信息以评估重排患者的长期预后。

结果

1056例连续患者中重排的发生率为6.6%。PSM后共确定70例阳性患者和210例阴性患者。影像学和病理分析显示,重排与较少的磨玻璃影(GGO)显著相关(校正OR=1.38,95%CI=1.03-1.85,=0.029),且非侵袭性黏液腺癌(非IMA MLA)的发生率较高(校正OR=6.79,95%CI=2.69-17.17,<0.001)。发现重排是女性患者无病生存期(DFS)的不良预后因素(HR=2.26,95%CI=1.13-4.53,=0.021)。

结论

我们的结果表明,与阴性腺癌相比,携带融合基因的腺癌具有特定的放射学和病理特征。在女性患者中,重排与较短的DFS相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad7/6986412/5db62a8455ef/CMAR-12-589-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验